Insulet (PODD) EPS (Weighted Average and Diluted) Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -19.74% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.20% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.00% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 88.89% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 47.37% |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn | 160.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 160.00% |
| Dec 31, 2025 | 3.62% |
| Sep 30, 2025 | 14.81% |
| Jun 30, 2025 | -87.64% |
| Mar 31, 2025 | -31.51% |
| Dec 31, 2024 | -6.12% |
| Sep 30, 2024 | 45.95% |
| Jun 30, 2024 | 564.10% |
| Mar 31, 2024 | 114.71% |
| Dec 31, 2023 | 488.00% |
| Sep 30, 2023 | 1,025.00% |
| Jun 30, 2023 | 178.00% |
| Mar 31, 2023 | -15.00% |
| Dec 31, 2022 | -40.48% |
| Sep 30, 2022 | -144.44% |
| Jun 30, 2022 | -35.14% |
| Dec 31, 2021 | 261.54% |
| Sep 30, 2021 | 5.88% |
| Jun 30, 2021 | -268.18% |
| Dec 31, 2020 | -425.00% |
| Sep 30, 2020 | 1,600.00% |
| Jun 30, 2020 | 1,000.00% |
| Mar 31, 2020 | -142.86% |
| Dec 31, 2019 | -50.00% |
| Sep 30, 2019 | -66.67% |
| Jun 30, 2019 | 166.67% |
| Mar 31, 2019 | 163.64% |
| Dec 31, 2018 | 233.33% |
| Sep 30, 2018 | 175.00% |
| Dec 31, 2017 | -20,306.37% |